Role of heparan sulfate in fibroblast growth factor signalling: a structural view.
暂无分享,去创建一个
[1] G. Giménez-Gallego,et al. Sequence Analysis of Heparan Sulfate Epitopes with Graded Affinities for Fibroblast Growth Factors 1 and 2* , 2001, The Journal of Biological Chemistry.
[2] M. Mohammadi,et al. Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[3] R. Vivès,et al. Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is dependent on specific structural features: differential requirements for the modulation of FGF-1 and FGF-2. , 2000, Glycobiology.
[4] David F. Burke,et al. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin , 2000, Nature.
[5] J. Schlessinger,et al. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. , 2000, Molecular cell.
[6] M. Salmivirta,et al. Selectively Desulfated Heparin Inhibits Fibroblast Growth Factor-induced Mitogenicity and Angiogenesis* , 2000, The Journal of Biological Chemistry.
[7] Joseph Schlessinger,et al. Crystal Structures of Two FGF-FGFR Complexes Reveal the Determinants of Ligand-Receptor Specificity , 2000, Cell.
[8] D. Ornitz,et al. FGFs, heparan sulfate and FGFRs: complex interactions essential for development. , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.
[9] W. Hendrickson,et al. Structural interactions of fibroblast growth factor receptor with its ligands. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[10] J. Turnbull,et al. Fibroblast growth factor receptor signalling is dictated by specific heparan sulphate saccharides , 1999, Current Biology.
[11] S. Hubbard,et al. Structural Basis for FGF Receptor Dimerization and Activation , 1999, Cell.
[12] R. Pettersson,et al. Characterization of fibroblast growth factor 1 binding heparan sulfate domain. , 1999, Glycobiology.
[13] J. Gallagher,et al. Monomer Complexes of Basic Fibroblast Growth Factor and Heparan Sulfate Oligosaccharides Are the Minimal Functional Unit for Cell Activation* , 1999, The Journal of Biological Chemistry.
[14] J. Turnbull,et al. Heparan Sulfate Oligosaccharides Require 6-O-Sulfation for Promotion of Basic Fibroblast Growth Factor Mitogenic Activity* , 1998, The Journal of Biological Chemistry.
[15] Wayne A. Hendrickson,et al. Structure of a heparin-linked biologically active dimer of fibroblast growth factor , 1998, Nature.
[16] R. Powers,et al. Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor. , 1997, Biochemistry.
[17] D C Rees,et al. Heparin Structure and Interactions with Basic Fibroblast Growth Factor , 1996, Science.
[18] K. Yoshida,et al. Importance of 2-O-sulfate groups of uronate residues in heparin for activation of FGF-1 and FGF-2. , 1995, Journal of biochemistry.
[19] M. Jaye,et al. Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation , 1994, Cell.
[20] M. Ishihara. Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2. , 1994, Glycobiology.
[21] M. Pantoliano,et al. Identification and concerted function of two receptor binding surfaces on basic fibroblast growth factor required for mitogenesis. , 1994, The Journal of biological chemistry.
[22] J. Lear,et al. Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. , 1994, Biochemistry.
[23] P. Dell’Era,et al. Distinct role of 2-O-, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1. , 1994, Biochemical and biophysical research communications.
[24] M. Pantoliano,et al. Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain. , 1994, Biochemistry.
[25] D. Rifkin,et al. Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. , 1994, The Journal of biological chemistry.
[26] B. Olwin,et al. Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. , 1993, The Journal of biological chemistry.
[27] D. Rees,et al. Three-dimensional structures of acidic and basic fibroblast growth factors. , 1993, Science.
[28] J. Xu,et al. An essential heparin-binding domain in the fibroblast growth factor receptor kinase. , 1993, Science.
[29] L. Cousens,et al. Preparation of affinity-fractionated, heparin-derived oligosaccharides and their effects on selected biological activities mediated by basic fibroblast growth factor. , 1993, The Journal of biological chemistry.
[30] J. Turnbull,et al. Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. , 1992, The Journal of biological chemistry.
[31] J G Flanagan,et al. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells , 1992, Molecular and cellular biology.
[32] Jeffrey D. Esko,et al. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.
[33] M. Jaye,et al. Effect of heparin on the binding affinity of acidic FGF for the cloned human FGF receptors, flg and bek. , 1990, Biochemical and biophysical research communications.
[34] M. Petitou,et al. Heparin‐derived oligosaccharides: Affinity for acidic fibroblast growth factor and effect on its growth‐promoting activity for human endothelial cells , 1989, Journal of cellular physiology.
[35] J. Folkman,et al. Importance of size, sulfation, and anticoagulant activity in the potentiation of acidic fibroblast growth factor by heparin. , 1989, Journal of Biological Chemistry.